+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alcohol Use Disorder Market by Drug Class (Acamprosate, Disulfiram, Naltrexone), Treatment Type (Behavioral Therapy, Combined Therapy, Pharmacotherapy), End User, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
Alcohol Use Disorder Market by Drug Class (Acamprosate, Disulfiram, Naltrexone), Treatment Type (Behavioral Therapy, Combined Therapy, Pharmacotherapy), End User, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
Sale

Alcohol Use Disorder Market by Drug Class (Acamprosate, Disulfiram, Naltrexone), Treatment Type (Behavioral Therapy, Combined Therapy, Pharmacotherapy), End User, Distribution Channel, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967604
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The alcohol use disorder market is undergoing significant transformation, driven by diverse advancements in therapy, technology adoption, and evolving regulatory environments. Senior decision-makers seeking to optimize investment in this sector must navigate a landscape defined by innovation, segmentation complexity, and global policy developments.

Market Snapshot: Alcohol Use Disorder Market

The Alcohol Use Disorder Market grew from USD 1.28 billion in 2024 to USD 1.37 billion in 2025. It is expected to continue growing at a CAGR of 6.60%, reaching USD 1.88 billion by 2030. This growth trajectory reflects an expanding demand for evidence-based interventions, increasing digital health integration, and proactive regulatory strategies across major regions.

Scope & Segmentation

  • Drug Class: Acamprosate (effervescent tablet, oral tablet); Disulfiram (oral tablet); Naltrexone (injectable, oral tablet)
  • Treatment Type: Behavioral Therapy (cognitive behavioral therapy, family therapy, motivational enhancement therapy); Combined Therapy (CBT with pharmacotherapy, MET with pharmacotherapy); Pharmacotherapy (injectable drugs, oral drugs)
  • End User: Home healthcare (home visits, telehealth), hospitals (private, public), rehabilitation centers (inpatient, outpatient), specialty clinics (alcohol rehabilitation, psychiatric clinics)
  • Distribution Channel: Hospital pharmacies (private, public), online pharmacies (e-commerce websites, mobile apps), retail pharmacies (chain, independent), specialty pharmacies (AUD specialty, general specialty)
  • Formulation: Dispersible tablet, effervescent tablet, injectable (intramuscular, intravenous, subcutaneous), oral tablet (immediate release, sustained release)
  • Regional Coverage: Americas (including United States, Canada, Brazil, Mexico, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, and others); Asia-Pacific (including China, India, Japan, Australia, and other key territories)
  • Key Technologies: Digital health platforms, telehealth, remote monitoring, mobile health applications

Key Takeaways for Senior Decision-Makers

  • Integrated care models, combining pharmacotherapies and psychosocial interventions, are increasingly prioritized for effectiveness and patient engagement.
  • Digital health and telehealth innovations have become essential for reaching underserved populations and improving adherence through real-time, personalized interventions.
  • Shifting societal attitudes and expanding policy reforms continue to boost coverage and acceptance of addiction treatment services, reinforcing holistic approaches throughout the care continuum.
  • Collaboration between pharmaceutical, biotech, and technology companies is advancing novel treatment mechanisms and patient-centric solutions.
  • Regional disparities in infrastructure and regulatory complexity require adaptive strategies for market entry, pricing, and engagement to ensure accessibility and sustained market growth.
  • Ongoing enhancements in formulation and delivery systems, such as long-acting injectables and user-friendly oral options, respond to adherence challenges and market competitiveness.

Assessing Tariff Impact on Supply Chain Resiliency

With new United States tariffs coming into effect in 2025, manufacturing costs for alcohol use disorder treatments may rise, primarily due to import duties on active pharmaceutical ingredients and specialty excipients. These changes prompt companies to strengthen local supplier relationships and diversify logistic partners. Heightened price sensitivity among payers and patients may drive firms to seek efficiencies and cost-saving alliances. Proactive scenario planning and supply chain diversification will be critical to maintain patient access and business sustainability.

Methodology & Data Sources

This report utilizes a rigorous mixed-methods approach, integrating primary interviews with clinicians, regulatory and reimbursement experts, and payers. Secondary research includes journal reviews, regulatory filings, white papers, and corporate disclosures. Data triangulation was implemented to verify findings, and stringent quality controls ensured segmentation and regional analyses remain robust and current.

Why This Report Matters

  • Enables senior leaders to make informed strategic decisions by delivering structured segmentation insights, regional analysis, and technology adoption trends for alcohol use disorder.
  • Equips organizations to anticipate and respond proactively to market shifts, policy changes, and supply chain risks.
  • Offers actionable recommendations to align corporate innovations with evolving patient needs and regulatory environments.

Conclusion

This research provides a concise, actionable overview of the alcohol use disorder market’s current state and evolving opportunities. Stakeholders are equipped to drive innovation, enhance patient outcomes, and succeed in an increasingly complex market landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital therapeutics and telehealth solutions in evidence-based alcohol use disorder treatment to improve patient outcomes
5.2. Rising adoption of AI-driven predictive analytics in mobile health apps to personalize alcohol craving management and relapse prevention
5.3. Emergence of long-acting injectable naltrexone and other advanced extended-release medications to enhance adherence in alcohol use disorder therapy
5.4. Rapid growth of telepsychiatry platforms enabling remote counseling and medication management for individuals with alcohol use disorder
5.5. Development of precision medicine strategies leveraging genetic and neurobiological biomarkers to tailor pharmacotherapy in alcohol use disorder
5.6. Increasing integration of virtual reality exposure therapy with cognitive behavioral counseling to address alcohol use disorder triggers more effectively
5.7. Expansion of employer-sponsored digital intervention programs incorporating remote monitoring and peer support for alcohol use disorder recovery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Alcohol Use Disorder Market, by Drug Class
8.1. Introduction
8.2. Acamprosate
8.2.1. Effervescent Tablet
8.2.2. Oral Tablet
8.3. Disulfiram
8.3.1. Oral Tablet
8.4. Naltrexone
8.4.1. Injectable
8.4.2. Oral Tablet
9. Alcohol Use Disorder Market, by Treatment Type
9.1. Introduction
9.2. Behavioral Therapy
9.2.1. Cognitive Behavioral Therapy
9.2.2. Family Therapy
9.2.3. Motivational Enhancement Therapy
9.3. Combined Therapy
9.3.1. Cbt With Pharmacotherapy
9.3.2. Met With Pharmacotherapy
9.4. Pharmacotherapy
9.4.1. Injectable Drugs
9.4.2. Oral Drugs
10. Alcohol Use Disorder Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.2.1. Home Visits
10.2.2. Telehealth
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Rehabilitation Centers
10.4.1. Inpatient
10.4.2. Outpatient
10.5. Specialty Clinics
10.5.1. Alcohol Rehabilitation Clinics
10.5.2. Psychiatric Clinics
11. Alcohol Use Disorder Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private Hospital Pharmacies
11.2.2. Public Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. E-Commerce Websites
11.3.2. Mobile Apps
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
11.5. Specialty Pharmacies
11.5.1. Aud Specialty Pharmacies
11.5.2. General Specialty Pharmacies
12. Alcohol Use Disorder Market, by Formulation
12.1. Introduction
12.2. Dispersible Tablet
12.3. Effervescent Tablet
12.4. Injectable
12.4.1. Intramuscular
12.4.2. Intravenous
12.4.3. Subcutaneous
12.5. Oral Tablet
12.5.1. Immediate Release
12.5.2. Sustained Release
13. Americas Alcohol Use Disorder Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Alcohol Use Disorder Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Alcohol Use Disorder Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alkermes plc
16.3.2. H. Lundbeck A/S
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Viatris Inc.
16.3.5. Sandoz International GmbH
16.3.6. Dr. Reddy’s Laboratories Ltd.
16.3.7. Sun Pharmaceutical Industries Ltd.
16.3.8. Aurobindo Pharma Ltd.
16.3.9. Lupin Limited
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ALCOHOL USE DISORDER MARKET: RESEARCHAI
FIGURE 26. ALCOHOL USE DISORDER MARKET: RESEARCHSTATISTICS
FIGURE 27. ALCOHOL USE DISORDER MARKET: RESEARCHCONTACTS
FIGURE 28. ALCOHOL USE DISORDER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 241. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 242. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 243. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 244. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 245. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 246. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 247. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 248. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 249. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 252. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 253. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2024 (USD MILLION)
TABLE 254. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2025-2030 (USD MILLION)
TABLE 255. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 256. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 257. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 260. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 261. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
TABLE 264. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2025-2030 (USD MILLION)
TABLE 265. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 280. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 281. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 282. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 283. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 285. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 288. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 289. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 292. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 293. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 294. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 295. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2024 (USD MILLION)
TABLE 296. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2025-2030 (USD MILLION)
TABLE 297. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 298. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 299. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 302. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 303. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
TABLE 306. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2025-2030 (USD MILLION)
TABLE 307. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 312. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 313. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 322. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 323. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 324. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL ALCOHOL USE DISORDER MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Alcohol Use Disorder market report include:
  • Alkermes plc
  • H. Lundbeck A/S
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Lupin Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.88 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Medications for Alcohol Use Disorder Market by Product Type (Injectables, Oral Tablets), Drug Class (Acamprosate, Baclofen, Disulfiram) - Global Forecast 2025-2030 - Product Image

Medications for Alcohol Use Disorder Market by Product Type (Injectables, Oral Tablets), Drug Class (Acamprosate, Baclofen, Disulfiram) - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Disulfiram Market by Manufacturer Type (Branded, Generic), Indication (Alcohol Dependence, Off Label), Distribution Channel, End User, Dosage Strength, Therapy Regimen - Global Forecast 2025-2030 - Product Image

Disulfiram Market by Manufacturer Type (Branded, Generic), Indication (Alcohol Dependence, Off Label), Distribution Channel, End User, Dosage Strength, Therapy Regimen - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Alcohol Use Disorder Market Report and Forecast 2025-2034 - Product Image

Alcohol Use Disorder Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2025 - Product Image

Alcohol Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Alcohol Abuse Monitoring Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Alcohol Abuse Monitoring Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From

About the Alcoholism Market

Alcoholism is a form of drug abuse that is characterized by a strong craving for alcohol and an inability to control its consumption. It is a chronic, progressive disorder that can lead to physical, psychological, and social problems. Drug abuse screening is a process used to identify individuals who are at risk for developing an alcohol or drug problem. Screening typically involves a questionnaire or interview that assesses an individual's drinking habits, family history of substance abuse, and other risk factors. Screening for alcohol abuse is an important part of the prevention and treatment of alcoholism. It can help identify individuals who are at risk for developing an alcohol problem and provide them with the necessary resources to prevent or reduce their alcohol consumption. Screening can also help identify individuals who are already suffering from alcohol abuse and provide them with the necessary treatment and support. Companies in the Alcoholism market include Alcoholics Anonymous, Al-Anon, and SMART Recovery. Other organizations that provide support and resources for individuals with alcohol abuse issues include the National Institute on Alcohol Abuse and Alcoholism, the Substance Abuse and Mental Health Services Administration, and the American Society of Addiction Medicine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.